Estrogen replacement therapy.
The popularity of estrogen therapy for the menopausal woman seems to be on the rise again, with new evidence on the risks and treatment of osteoporosis and the protective effect of progestin on the endometrium becoming clearer. The risks of estrogen treatment must remain a prime concern of the practitioner, and hazards may be minimized through careful patient selection, education, examination, treatment, and follow-up. The resurgence of interest in the plight of the menopausal woman has stimulated an increasing number of competent investigators to attempt to solve the mysteries that until recently have been evaluated and treated by anecdote and homeopathic ministrations.
D000328:Adult; D000368:Aged; D000568:Amenorrhea / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D001634:Bibliographies as Topic; D001786:Blood Glucose / Q000378:metabolism; D001941:Breast Diseases / Q000139:chemically induced; D002769:Cholelithiasis / Q000139:chemically induced; D002979:Climacteric / Q000187:drug effects*; D003327:Coronary Disease / Q000139:chemically induced; D004715:Endometriosis / Q000139:chemically induced; D004958:Estradiol / Q000172:deficiency; D004967:Estrogens / Q000009:adverse effects / Q000096:biosynthesis / Q000266:history / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D049672:History, 19th Century; D049673:History, 20th Century; D049690:History, Ancient; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008297:Male; D008593:Menopause; D008875:Middle Aged; D010024:Osteoporosis / Q000188:drug therapy; D013923:Thromboembolism / Q000139:chemically induced
D001786:Blood Glucose; D004967:Estrogens; D004958:Estradiol